Pitch 2-4 : Takuji Yamamoto, Matrixome, Inc.
Cell culture substrate stands on 'MATRIXOME'
CEO, Matrixome, Inc.
山本 卓司 氏
|Speaker Profile||Mr. Yamamoto has had researched about prion disease and developed BSE/ TSE detection kit in Nippi Research Institute for BioMatrix. After developed that product, he has been researched and developed laminin-E8 fragment, and built Matrixome, Inc. with Prof. Sekiguchi for accelerating the research about matrixome. He became CEO at Jan. 2016.|
HVC KYOTO 2018 will be held on July 3rd 2018!
Click here for the program.
To attend the event, please fill out the form from here!
HVC KYOTO 2018は2018/7/3に開催いたします。
当日のプログラムは こちら をご覧ください。
HVC KYOTO 2018への参加お申し込みは こちら から。